263 related articles for article (PubMed ID: 26633557)
1. FAT4 functions as a tumour suppressor in gastric cancer by modulating Wnt/β-catenin signalling.
Cai J; Feng D; Hu L; Chen H; Yang G; Cai Q; Gao C; Wei D
Br J Cancer; 2015 Dec; 113(12):1720-9. PubMed ID: 26633557
[TBL] [Abstract][Full Text] [Related]
2. FAT4 silencing promotes epithelial-to-mesenchymal transition and invasion via regulation of YAP and β-catenin activity in ovarian cancer.
Malgundkar SH; Burney I; Al Moundhri M; Al Kalbani M; Lakhtakia R; Okamoto A; Tamimi Y
BMC Cancer; 2020 May; 20(1):374. PubMed ID: 32366234
[TBL] [Abstract][Full Text] [Related]
3. Fat4 suppression induces Yap translocation accounting for the promoted proliferation and migration of gastric cancer cells.
Ma L; Cui J; Xi H; Bian S; Wei B; Chen L
Cancer Biol Ther; 2016; 17(1):36-47. PubMed ID: 26575609
[TBL] [Abstract][Full Text] [Related]
4. miR-107 regulates growth and metastasis of gastric cancer cells via activation of the PI3K-AKT signaling pathway by down-regulating FAT4.
Wang L; Li K; Wang C; Shi X; Yang H
Cancer Med; 2019 Sep; 8(11):5264-5273. PubMed ID: 31297980
[TBL] [Abstract][Full Text] [Related]
5. FAT4 regulates the EMT and autophagy in colorectal cancer cells in part via the PI3K-AKT signaling axis.
Wei R; Xiao Y; Song Y; Yuan H; Luo J; Xu W
J Exp Clin Cancer Res; 2019 Mar; 38(1):112. PubMed ID: 30832706
[TBL] [Abstract][Full Text] [Related]
6. EphA2 promotes epithelial-mesenchymal transition through the Wnt/β-catenin pathway in gastric cancer cells.
Huang J; Xiao D; Li G; Ma J; Chen P; Yuan W; Hou F; Ge J; Zhong M; Tang Y; Xia X; Chen Z
Oncogene; 2014 May; 33(21):2737-47. PubMed ID: 23752181
[TBL] [Abstract][Full Text] [Related]
7. FAT4 loss initiates hepatocarcinogenesis through the switching of canonical to noncanonical WNT signaling pathways.
Huang FY; Wong DK; Mak LY; Cheung TT; Zhang SS; Chau HT; Hui RW; Seto WK; Yuen MF
Hepatol Commun; 2023 Dec; 7(12):. PubMed ID: 38055646
[TBL] [Abstract][Full Text] [Related]
8. miR-302b inhibits tumorigenesis by targeting EphA2 via Wnt/ β-catenin/EMT signaling cascade in gastric cancer.
Huang J; He Y; Mcleod HL; Xie Y; Xiao D; Hu H; Chen P; Shen L; Zeng S; Yin X; Ge J; Li L; Tang L; Ma J; Chen Z
BMC Cancer; 2017 Dec; 17(1):886. PubMed ID: 29273006
[TBL] [Abstract][Full Text] [Related]
9. Cyclin G2 suppresses Wnt/β-catenin signaling and inhibits gastric cancer cell growth and migration through Dapper1.
Gao J; Zhao C; Liu Q; Hou X; Li S; Xing X; Yang C; Luo Y
J Exp Clin Cancer Res; 2018 Dec; 37(1):317. PubMed ID: 30547803
[TBL] [Abstract][Full Text] [Related]
10. CCT5 induces epithelial-mesenchymal transition to promote gastric cancer lymph node metastasis by activating the Wnt/β-catenin signalling pathway.
Li Y; Liu C; Zhang X; Huang X; Liang S; Xing F; Tian H
Br J Cancer; 2022 Jun; 126(12):1684-1694. PubMed ID: 35194191
[TBL] [Abstract][Full Text] [Related]
11. Transducin (β)-like 1 X-linked receptor 1 promotes gastric cancer progression via the ERK1/2 pathway.
Zhou Q; Wang X; Yu Z; Wu X; Chen X; Li J; Zhu Z; Liu B; Su L
Oncogene; 2017 Mar; 36(13):1873-1886. PubMed ID: 27694893
[TBL] [Abstract][Full Text] [Related]
12. Frizzled7 Promotes Epithelial-to-mesenchymal Transition and Stemness Via Activating Canonical Wnt/β-catenin Pathway in Gastric Cancer.
Li G; Su Q; Liu H; Wang D; Zhang W; Lu Z; Chen Y; Huang X; Li W; Zhang C; He Y; Fu L; Bi J
Int J Biol Sci; 2018; 14(3):280-293. PubMed ID: 29559846
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of long noncoding RNA LINC00460 expression suppresses tumor growth in vitro and in vivo in gastric cancer.
Zhang S; Xu J; Wang H; Guo H
Cancer Biomark; 2019; 24(4):429-437. PubMed ID: 30909185
[TBL] [Abstract][Full Text] [Related]
14. ERp29 controls invasion and metastasis of gastric carcinoma by inhibition of epithelial-mesenchymal transition via PI3K/Aktsignaling pathway.
Ye J; Huang J; Xu J; Huang Q; Wang J; Zhong W; Lin X; Li Y; Lin X
BMC Cancer; 2017 Sep; 17(1):626. PubMed ID: 28874138
[TBL] [Abstract][Full Text] [Related]
15. JMJD2B promotes epithelial-mesenchymal transition by cooperating with β-catenin and enhances gastric cancer metastasis.
Zhao L; Li W; Zang W; Liu Z; Xu X; Yu H; Yang Q; Jia J
Clin Cancer Res; 2013 Dec; 19(23):6419-29. PubMed ID: 24077348
[TBL] [Abstract][Full Text] [Related]
16. RSPO2 enhances cell invasion and migration via the WNT/β-catenin pathway in human gastric cancer.
Zhang H; Han X; Wei B; Fang J; Hou X; Lan T; Wei H
J Cell Biochem; 2019 Apr; 120(4):5813-5824. PubMed ID: 30362605
[TBL] [Abstract][Full Text] [Related]
17. RACK1 suppresses gastric tumorigenesis by stabilizing the β-catenin destruction complex.
Deng YZ; Yao F; Li JJ; Mao ZF; Hu PT; Long LY; Li G; Ji XD; Shi S; Guan DX; Feng YY; Cui L; Li DS; Liu Y; Du X; Guo MZ; Xu LY; Li EM; Wang HY; Xie D
Gastroenterology; 2012 Apr; 142(4):812-823.e15. PubMed ID: 22240482
[TBL] [Abstract][Full Text] [Related]
18. Wnt pathway is involved in advanced gastric carcinoma.
Zhang H; Xue Y
Hepatogastroenterology; 2008; 55(84):1126-30. PubMed ID: 18705344
[TBL] [Abstract][Full Text] [Related]
19. PCDHGA9 represses epithelial-mesenchymal transition and metastatic potential in gastric cancer cells by reducing β-catenin transcriptional activity.
Weng J; Li S; Lin H; Mei H; Liu Y; Xiao C; Zhu Z; Cai W; Ding X; Mi Y; Wen Y
Cell Death Dis; 2020 Mar; 11(3):206. PubMed ID: 32231199
[TBL] [Abstract][Full Text] [Related]
20. PRRX1 promotes epithelial-mesenchymal transition through the Wnt/β-catenin pathway in gastric cancer.
Guo J; Fu Z; Wei J; Lu W; Feng J; Zhang S
Med Oncol; 2015 Jan; 32(1):393. PubMed ID: 25428393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
